Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

CLARITHROMYCIN EXTENDED-RELEASE- clarithromycin tablet, extended release

Provide The Following Instructions Or Information About Clarithromycin To Patients:

  • Counsel patients that antibacterial drugs including clarithromycin should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When clarithromycin is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by clarithromycin or other antibacterial drugs in the future.
  • Advise patients that diarrhea is a common problem caused by antibacterials including clarithromycin which usually ends when the antibacterial is discontinued. Sometimes after starting treatment with antibacterials, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibacterial. If this occurs, instruct patients to contact their healthcare provider as soon as possible.
  • Advise patients that clarithromycin may interact with some drugs; therefore, advise patients to report to their healthcare provider the use of any other medications.
  • Advise patients that clarithromycin tablets and oral suspension can be taken with or without food and can be taken with milk; however, clarithromycin extended-release tablets should be taken with food. Do not refrigerate the suspension.
  • There are no data on the effect of clarithromycin on the ability to drive or use machines. However, counsel patients regarding the potential for dizziness, vertigo, confusion and disorientation, which may occur with the medication. The potential for these adverse reactions should be taken into account before patients drive or use machines.
  • Advise patients that if pregnancy occurs while taking this drug, there is a potential hazard to the fetus[seeWarnings and Precautions (5.6)andUse in Specific Populations (8.1)].

All brand names listed are the registered trademarks of their respective owners and are not trademarks of Par Pharmaceutical.

Dist. by:
Estreno Pharmaceutical
Sunrise, FL 33323 U.S.A.

Rev 012018

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: